Pharmacokinetics of the amidine prodrug of a novel oral anticoagulant factor VIIa inhibitor (AS1924269-00) in rats

Author： Nakabayashi T.   Gotoh Y.   Kamada N.   Fujioka M.   Ishihara T.   Hirabayashi A.   Sato H.  

Publisher： Govi-Verlag

ISSN： 0031-7144

Source： Die Pharmazie - An International Journal of Pharmaceutical Sciences, Vol.68, Iss.5, 2013-05, pp. : 349-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Inhibitors of Tissue Factor•Factor VIIa for Anticoagulant Therapy

By  

Current Medicinal Chemistry, Vol. 11, Iss. 17, 2004-09 ,pp. : 2275-2290

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacokinetics and Pharmacodynamics of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor

By  

Current Clinical Pharmacology, Vol. 9, Iss. 1, 2014-02 ,pp. : 75-83

Bentham Science Publishers

Access to resources Recommend Favorite

Ximelagatran: An Oral Direct Thrombin Inhibitor for Anticoagulant Therapy

By  

Letters in Drug Design & Discovery, Vol. 2, Iss. 7, 2005-11 ,pp. : 503-506

Bentham Science Publishers

Access to resources Recommend Favorite

Novel oral anticoagulants: focus on the direct factor Xa inhibitor darexaban

By Apostolakis Stavros   Lip Gregory YH  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 7, 2012-07 ,pp. : 1057-1064

Informa Healthcare

Access to resources Recommend Favorite

Population Pharmacokinetics and Pharmacodynamics of Rivaroxaban - an Oral, Direct Factor Xa Inhibitor - in Patients Undergoing Major Orthopaedic Surgery

By Mueck Wolfgang  

Clinical Pharmacokinetics, Vol. 47, Iss. 3, 2008-01 ,pp. : 203-216

Adis International

Access to resources Recommend Favorite